HCA’s lobby is now open for walk-in customer service. Learn about customer service options.

Prescription drug price transparency

Reporting entity resources (carriers, manufacturers, PBMs, PSAOs)

The following resources are for reporting entities who may need assistance.

The excel templates below are available as an aid if you are hand-keying data for submissions to the Drug Price Transparency program. These workbooks are programmed with simple rules that will help you avoid some common errors that can occur.

Important note about Excel version: We recommend using Microsoft Excel 2016 or earlier for the submission guides. Using Microsoft Excel 2019 can cause formatting issues when saving as a CSV file.

All

Reporting entity registration form
Reporting entity extension request form
Reporting entity data resubmission form
When using this form:
- You must resubmit the entire report.
- The report name must match previously submitted report name.
Data submission FAQ (updated 12/1/2021)

Carriers

Data submission guide v3.0 - draft (carrier feedback due by May 5, 2022)
Change summary

Report year 2020 (due date: December 1, 2021)

Report years 2018 - 2019

Manufacturers

Report year 2022

Pharmacy Benefit Managers (PBMs)

Report year 2020 (due date: March 1, 2022)

Report years 2018-2019

Pharmacy Services Administrative Organizations (PSAOs)

Data submission guide v3.0 - draft (PSAO feedback due by May 5, 2022)
Change summary

Report year 2020 (due date: December 1, 2021)

Stakeholder meetings

At each meeting, HCA will give a short overview of Chapter 43.71C RCW then use the majority of time to take questions and hear concerns from stakeholders. We will focus on a different supplier in each meeting. The public is invited to participate in any of the meetings.

Meeting schedule

Date and time	Meeting type	Materials
July 28, 2021	PBM listening session	Slide deck Listening session audio
July 22, 2021	Manufacturer listening session	Slide deck Listening session audio
July 6, 2021	Carrier listening session	Slide deck Listening session audio
April 29, 2020	Pharmacy benefit manager / pharmacy service administrative organization reporting Webinar only, no in person meeting due to COVID-19	Slide deck Recorded webinar
April 1, 2020	Issuer / carrier reporting Webinar only, no in person meeting due to COVID-19	Updated slide deck Recorded webinar
February 26, 2020	Manufacturer reporting	Slide deck Recorded webinar

Background

In 2019, the Washington State Legislature passed Engrossed Second Substitute House Bill into law. This law requires issuers of health insurance, pharmacy benefit managers (PBMs), manufacturers, and pharmacy service administrative organizations (PSAOs) to submit data to the Health Care Authority (HCA). The purpose is to create an annual report on how prescription drugs affect health care costs. The law also requires pharmaceutical manufacturers to submit data to HCA relating the new drug applications (NDA).